Cutler Group LP Sellas Life Sciences Group, Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$2.02 - $5.41 $2,424 - $6,492	-1,200 Reduced 80.0%	300 $0
Q3 2022 Oct 25, 2022	SELL	$2.1 - $3.38 $1,050 - $1,690	-500 Reduced 25.0%	1,500 $3,000
Q1 2022 Apr 14, 2022	BUY	$4.73 - $7.18 $9,460 - $14,360	2,000 New	2,000 $13,000
Q4 2021 Jan 18, 2022	SELL	$5.36 - $9.53 $1,072 - $1,905	-200 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$8.21 - $10.53 $55,007 - $70,551	-6,700 Reduced 97.1%	200 $1,000

Q2 2021 Jul 19, 2021	SELL	$7.19 - $13.71 $74,776 - $142,584	-10,400 Reduced 60.12%	6,900 $76,000
Q1 2021 Apr 26, 2021	BUY	$5.5 - $11.71 $95,150 - $202,583	17,300 New	17,300 $147,000

8.03M

2.52M

24.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $24.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.